NANCY SEIGLE LESPERANCE: Open Payments
NPI 1851403554 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 7 payments from 4 companies in 2025. Trend: 2023 $217 · 2024 $743 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 2 | $133 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: AMVUTTRA, VERQUVO, FARXIGA, CAMZYOS.
Industry payments across GA — which companies pay providers there.
